{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:56:57Z","timestamp":1791089817761,"version":"4.1.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/qai.0b013e3181b9869f","type":"journal-article","created":{"date-parts":[[2009,12,22]],"date-time":"2009-12-22T03:18:55Z","timestamp":1261451935000},"page":"86-94","source":"Crossref","is-referenced-by-count":235,"title":["Declines in Mortality Rates and Changes in Causes of Death in HIV-1-Infected Children During the HAART Era"],"prefix":"10.1097","volume":"53","author":[{"given":"Michael T","family":"Brady","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Oleske","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paige L","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Elgie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne M","family":"Mofenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne M","family":"Dankner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell B","family":"Van Dyke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210131","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1056\/NEJMoa011157","article-title":"Pediatric AIDS Clinical Trials Group Protocol 219 Team. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.","volume":"345","author":"Gortmaker","year":"2001","journal-title":"N Engl J Med"},{"key":"R2-13-20210131","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1086\/526524","article-title":"Seage III GR for the PACTG219\/219C Study Team. Long-term Effectiveness of Highly Active Antiretroviral Therapy (HAART) on the Survival of Children and Adolescents infected with HIV-1.","volume":"46","author":"Patel","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R3-13-20210131","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00006454-200105000-00008","article-title":"New York City Pediatric Surveillance of Disease Consortium, Centers for Disease Control and Prevention. Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium.","volume":"20","author":"Abrams","year":"2001","journal-title":"Pediatr Infect Dis J"},{"key":"R4-13-20210131","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1001\/jama.284.2.190","article-title":"Reduction in mortality with availability of antiretroviral therapy for children with perinatal HIV-1 infection. Italian Register for HIV Infection in Children and the Italian National AIDS Registry.","volume":"284","author":"deMartino M, Tovo","year":"2000","journal-title":"JAMA"},{"key":"R5-13-20210131","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1086\/521167","article-title":"Moribidity, mortality and response to treatment in children in the United Kingdom and Ireland with perinatally-acquired HIV infection during 1996-2006: planning for teenage and adult care.","volume":"45","author":"Judd","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R6-13-20210131","first-page":"488","article-title":"Trends in antiretroviral therapy use and survival rates in HIV-infected children and adolescents in the United States, 1989-2001.","volume":"38","author":"McConnell","year":"2005","journal-title":"JAIDS"},{"key":"R7-13-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1086\/505147","article-title":"The survival benefits of AIDS treatment in the United States.","volume":"194","author":"Walensky","year":"2006","journal-title":"J Infect Dis"},{"key":"R8-13-20210131","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(03)13802-0","article-title":"Decline in the AIDS and death rates in the EuroSIDA study: an observational study.","volume":"362","author":"Mocroft","year":"2003","journal-title":"Lancet"},{"key":"R9-13-20210131","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"HIV Outpatient Study Investigators. Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-13-20210131","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1097\/00006454-199712000-00009","article-title":"Characteristics of human immunodeficiency virus-infected children at the time of death: an experience in the 1990s.","volume":"16","author":"Johann-Liang","year":"1997","journal-title":"Pediatr Infect Dis J"},{"key":"R11-13-20210131","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1542\/peds.107.2.328","article-title":"Human immunodeficiency virus related mortality in infants and children: data from the Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV (P2C2) study.","volume":"107","author":"Langston","year":"2001","journal-title":"Pediatrics"},{"key":"R12-13-20210131","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1097\/QAD.0b013e32823ecf5b","article-title":"Changing patterns of clinical events in perinatally HIV-1-infected children during the era of HAART.","volume":"21","author":"Chiappini","year":"2007","journal-title":"AIDS"},{"key":"R13-13-20210131","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/01.inf.0000214994.44346.d3","article-title":"Outcomes for human immunodeficiency virus-1-infected infants in the United Kingdom and Republic of Ireland in the era of effective antiretroviral therapy.","volume":"25","author":"Doerholt","year":"2006","journal-title":"Pediatr Infect Dis J"},{"key":"R14-13-20210131","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1001\/jama.296.3.292","article-title":"Incidence of opportunistic and other infections in HIV-infected children in the HAART era.","volume":"296","author":"Gona","year":"2006","journal-title":"JAMA"},{"key":"R15-13-20210131","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1542\/peds.109.4.e61","article-title":"Pediatrics AIDS Clinical Trials Group Adherence Subcommittee Pediatric AIDS Clinical Trials Group 377 Study Team. Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.","volume":"109","author":"VanDyke","year":"2002","journal-title":"Pediatrics"},{"key":"R16-13-20210131","first-page":"442","article-title":"Morbidity and mortality in European children vertically infected by HIV-1.","volume":"14","author":"Blanche","year":"1997","journal-title":"JAIDS"},{"key":"R17-13-20210131","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1056\/NEJMoa0800971","article-title":"Early antiretroviral therapy and mortality among HIV-infected infants.","volume":"359","author":"Violari","year":"200","journal-title":"N Eng J Med"},{"key":"R18-13-20210131","first-page":"1","article-title":"Guidelines for the use of antiretroviral agents in pediatric HIV infection.","volume":"47","year":"1998","journal-title":"MMWR"},{"key":"R19-13-20210131","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1086\/510495","article-title":"Treating Children with HIV Infection: What We Can Do, We Should Do.","volume":"44","author":"Oleske","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R20-13-20210131","first-page":"243","article-title":"When should we treat children with HIV?","volume":"82","author":"Oleske","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"R22-13-20210131","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/01.inf.0000073241.01043.9c","article-title":"Changes in deaths reported with human immunodeficiency virus infection among United States children less than thirteen years old, 1987 through 1999.","volume":"22","author":"Selik","year":"2003","journal-title":"Pediatr Infect Dis J"},{"key":"R23-13-20210131","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00467-004-1558-1","article-title":"A 20-year history of childhood HIV-associated nephropathy.","volume":"19","author":"Ray","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"R24-13-20210131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1056\/NEJM198909073211001","article-title":"Renal disease in children with acquired immunodeficiency syndrome.","volume":"321","author":"Strauss","year":"1989","journal-title":"N Engl J Med"},{"key":"R25-13-20210131","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000168835","article-title":"Zidovudine is beneficial in human immunodeficiency virus associated nephropathy.","volume":"15","author":"Ifudu","year":"1995","journal-title":"Am J Nephrol"},{"key":"R26-13-20210131","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1542\/peds.104.6.1394","article-title":"Resolution of HIV-associated nephropathy nephrotic syndrome with highly active antiretroviral therapy delivered by gastrostomy tube.","volume":"104","author":"Viani","year":"1999","journal-title":"Pediatrics"},{"key":"R27-13-20210131","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1002\/jmv.20940","article-title":"Prevalence and risk factors associated with antiretroviral resistance in HIV-1-infected children.","volume":"79","author":"Delaugerre","year":"2007","journal-title":"J Med Virol"},{"key":"R28-13-20210131","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1001\/jama.293.18.2213","article-title":"Antiretroviral treatment in pediatric HIV infection in the United States: from clinical trials to practice.","volume":"293","author":"Brogly","year":"2005","journal-title":"JAMA"},{"key":"R29-13-20210131","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1089\/jpm.2007.0148","article-title":"Do-not-resuscitate orders and\/o hospice care, psychological health and quality of life among children\/adolescents with acquired immune deficiency syndrome.","volume":"11","author":"Lyon","year":"2008","journal-title":"J Palliat Med"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00126334-201001010-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:11:00Z","timestamp":1786039860000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00126334-201001010-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e3181b9869f","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}